198 related articles for article (PubMed ID: 32133282)
41. A deep learning-based system for survival benefit prediction of tyrosine kinase inhibitors and immune checkpoint inhibitors in stage IV non-small cell lung cancer patients: A multicenter, prognostic study.
Deng K; Wang L; Liu Y; Li X; Hou Q; Cao M; Ng NN; Wang H; Chen H; Yeom KW; Zhao M; Wu N; Gao P; Shi J; Liu Z; Li W; Tian J; Song J
EClinicalMedicine; 2022 Sep; 51():101541. PubMed ID: 35813093
[TBL] [Abstract][Full Text] [Related]
42. Effectiveness of CT radiomic features combined with clinical factors in predicting prognosis in patients with limited-stage small cell lung cancer.
Wu J; Zhou Y; Xu C; Yang C; Liu B; Zhao L; Song J; Wang W; Yang Y; Liu N
BMC Cancer; 2024 Feb; 24(1):170. PubMed ID: 38310283
[TBL] [Abstract][Full Text] [Related]
43. CT Radiomics Predict EGFR-T790M Resistance Mutation in Advanced Non-Small Cell Lung Cancer Patients After Progression on First-line EGFR-TKI.
Tang X; Li Y; Shen LT; Yan WF; Qian WL; Yang ZG
Acad Radiol; 2023 Nov; 30(11):2574-2587. PubMed ID: 36941156
[TBL] [Abstract][Full Text] [Related]
44. [Semiquantitative parameters of
Liao XH; Wang RF; Liu M; Chen XQ; Xiong Y; Nong L; Yin L; Zhang BY; DU YJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 53(2):246-254. PubMed ID: 33879893
[TBL] [Abstract][Full Text] [Related]
45. Clinical Management of Non-Small Cell Lung Cancer with Concomitant EGFR Mutations and ALK Rearrangements: Efficacy of EGFR Tyrosine Kinase Inhibitors and Crizotinib.
Zhao Y; Wang S; Zhang B; Qiao R; Xu J; Zhang L; Zhang Y; Han B
Target Oncol; 2019 Apr; 14(2):169-178. PubMed ID: 30888598
[TBL] [Abstract][Full Text] [Related]
46. Biopsy Procedures and Molecular Testing Utilization and Related Costs in Patients with Metastatic Lung Cancer.
Shinde R; Cao X; Kothari S
J Manag Care Spec Pharm; 2016 Oct; 22(10):1194-203. PubMed ID: 27668568
[TBL] [Abstract][Full Text] [Related]
47. Conteltinib (CT-707) in patients with advanced ALK-positive non-small cell lung cancer: a multicenter, open-label, first-in-human phase 1 study.
Xing P; Zhao Q; Zhang L; Wang H; Huang D; Hu P; Sun Y; Shi Y
BMC Med; 2022 Nov; 20(1):453. PubMed ID: 36424628
[TBL] [Abstract][Full Text] [Related]
48. Parallel comparison and combining effect of radiomic and emerging genomic data for prognostic stratification of non-small cell lung carcinoma patients.
Kim KH; Kim J; Park H; Kim H; Lee SH; Sohn I; Lee HY; Park WY
Thorac Cancer; 2020 Sep; 11(9):2542-2551. PubMed ID: 32700470
[TBL] [Abstract][Full Text] [Related]
49. Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer Patients.
Britschgi C; Addeo A; Rechsteiner M; Delaloye R; Früh M; Metro G; Banini M; Gautschi O; Rothschild SI; Wild PJ; Banna GL; Curioni-Fontecedro A
Front Oncol; 2020; 10():1299. PubMed ID: 32974130
[No Abstract] [Full Text] [Related]
50. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
[TBL] [Abstract][Full Text] [Related]
51. Radiomic signature as a diagnostic factor for histologic subtype classification of non-small cell lung cancer.
Zhu X; Dong D; Chen Z; Fang M; Zhang L; Song J; Yu D; Zang Y; Liu Z; Shi J; Tian J
Eur Radiol; 2018 Jul; 28(7):2772-2778. PubMed ID: 29450713
[TBL] [Abstract][Full Text] [Related]
52. Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib.
Yang CY; Liao WY; Ho CC; Chen KY; Tsai TH; Hsu CL; Liu YN; Su KY; Chang YL; Wu CT; Liao BC; Hsu CC; Hsu WH; Lee JH; Lin CC; Shih JY; Yang JC; Yu CJ
Oncologist; 2020 Aug; 25(8):702-711. PubMed ID: 32386255
[TBL] [Abstract][Full Text] [Related]
53. CT radiomics-based prediction of anaplastic lymphoma kinase and epidermal growth factor receptor mutations in lung adenocarcinoma.
Choe J; Lee SM; Kim W; Do KH; Kim S; Choi S; Seo JB
Eur J Radiol; 2021 Jun; 139():109710. PubMed ID: 33862316
[TBL] [Abstract][Full Text] [Related]
54. Novel radiomic signature as a prognostic biomarker for locally advanced rectal cancer.
Meng Y; Zhang Y; Dong D; Li C; Liang X; Zhang C; Wan L; Zhao X; Xu K; Zhou C; Tian J; Zhang H
J Magn Reson Imaging; 2018 Feb; ():. PubMed ID: 29437271
[TBL] [Abstract][Full Text] [Related]
55. Predicting Chemo-Radiotherapy Sensitivity With Concordant Survival Benefit in Non-Small Cell Lung Cancer
Liu Y; Qi H; Wang C; Deng J; Tan Y; Lin L; Cui Z; Li J; Qi L
Front Oncol; 2022; 12():832343. PubMed ID: 35814422
[TBL] [Abstract][Full Text] [Related]
56. PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs.
Yang L; Xu P; Li M; Wang M; Peng M; Zhang Y; Wu T; Chu W; Wang K; Meng H; Zhang L
Front Oncol; 2022; 12():894323. PubMed ID: 35800046
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of PD-L1 Expression Level in Patients With Non-Small Cell Lung Cancer by
Li J; Ge S; Sang S; Hu C; Deng S
Front Oncol; 2021; 11():789014. PubMed ID: 34976829
[TBL] [Abstract][Full Text] [Related]
58. Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images.
van Timmeren JE; Leijenaar RTH; van Elmpt W; Reymen B; Oberije C; Monshouwer R; Bussink J; Brink C; Hansen O; Lambin P
Radiother Oncol; 2017 Jun; 123(3):363-369. PubMed ID: 28506693
[TBL] [Abstract][Full Text] [Related]
59. Value of interim
Shao D; Cheng Y; Yuan ZS; Jiang BY; Wang SX
Lung Cancer; 2020 Nov; 149():137-143. PubMed ID: 33011375
[TBL] [Abstract][Full Text] [Related]
60. The deep learning model combining CT image and clinicopathological information for predicting ALK fusion status and response to ALK-TKI therapy in non-small cell lung cancer patients.
Song Z; Liu T; Shi L; Yu Z; Shen Q; Xu M; Huang Z; Cai Z; Wang W; Xu C; Sun J; Chen M
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):361-371. PubMed ID: 32794105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]